Long-Term Follow-Up Outcome of Imatinib Mesylate Treatment for Recurrent and Unresectable Gastrointestinal Stromal Tumors

Publisher： Karger

E-ISSN： 1421-9867|87|1|47-52

ISSN： 0012-2823

Source： Digestion, Vol.87, Iss.1, 2013-01, pp. : 47-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Clinical Outcome of Patients with Gastric Gastrointestinal Stromal Tumors

By Maor Yaakov Avidan Benjamin Melzer Ehud Bar-Meir Simon

Digestive Diseases and Sciences, Vol. 55, Iss. 10, 2010-10 ,pp. : 2893-2898

Springer Publishing Company

Access to resources Recommend Favorite

Long-term follow-up of aortic intramural hematoma: predictors of outcome

By Evagelista A. Dominguez R. Sebastia C.

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 63-64

Elsevier

Access to resources Recommend Favorite

Successful resection of a giant recurrent gastrointestinal stromal tumour with imatinib mesylate as neoadjuvant therapy

By Yu Ji-Ren Yang Xiao-Jun Yang Wei-Li Gao Yuan Zhang Qing

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 9, 2007-01 ,pp. : 1138-1140

Informa Healthcare

Access to resources Recommend Favorite

A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients

By Sawaki Akira Yamao Kenji Nakamura Tsuneya Suzuki Takashi Okubo Kenji Hara Kazuo Kawai Hiroki Yamamura Yoshitaka Ito Seiji Mochiduki Yoshinari Ohno Ryuzo

Journal of Gastroenterology, Vol. 39, Iss. 4, 2004-04 ,pp. : 329-333

Springer Publishing Company

Access to resources Recommend Favorite

Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors

By Sicklick Jason Lopez Nicole

Journal of Gastrointestinal Surgery, Vol. 17, Iss. 11, 2013-11 ,pp. : 1997-2006

Springer Publishing Company

Access to resources Recommend Favorite